[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100396803":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":27,"responsibleParty":47,"collaborators":10,"id":50,"slug":10,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":51,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"University Hospital, Bonn","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"With TIPS",null,"Prospective cohort that received TIPS",{"label":13,"type":10,"description":14,"interventionNames":10},"Without TIPS","Prospective cohort that did not receive TIPS",[16],{"name":17,"affiliation":5,"role":18},"Michael Praktiknjo, MD","PRINCIPAL_INVESTIGATOR",[20,24],{"name":17,"role":21,"phone":22,"phoneExt":10,"email":23},"CONTACT","+49(0)228-287 15770","michael.praktiknjo@ukbonn.de",{"name":25,"role":21,"phone":22,"phoneExt":10,"email":26},"Johannes Chang, MD","johannes.chang@ukbonn.de",[28],{"facility":29,"status":30,"city":31,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"University Hospital Bonn","RECRUITING","Bonn","Germany","DE",{"type":35,"coordinates":36},"Point",[37,38],7.09549,50.73438,{"lat":38,"lon":37},[41,43,44],{"name":17,"role":21,"phone":42,"phoneExt":10,"email":23},"+49228 28715770",{"name":25,"role":21,"phone":42,"phoneExt":10,"email":26},{"name":45,"role":46,"phone":10,"phoneExt":10,"email":10},"Nina Böhling, MD","SUB_INVESTIGATOR",{"type":18,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Michael Praktiknjo","MD","100396803",false,"NCT04446858","Non-invasive Evaluation of the Predictive Value of CEUS and SWE in ACLF, Renal Failure and Hepatorenal Syndrome","Non-invasive Evaluation of the Predictive Value of CEUS and SWE in Patients With and Without TIPS With ACLF, Renal Failure and Hepatorenal Syndrome","NECTAR","Inclusion Criteria:\n\n* All patients with portal hypertension and kidney failure\n\nExclusion Criteria:\n\n* no consent, no kidney failure, no portal hypertension","ALL","18 Years","100 Years",{"count":61,"type":62},1000,"ESTIMATED","OBSERVATIONAL","Evaluation of non-invasive prognostic parameters in patients developing ACLF and renal failure in patients receiving and not receiving transjugular intrahepatic portosystemic shunt (TIPS). Patients are cared according to the local standardized follow up program. Clinical and laboratory data from standard patient care are evaluated for potential prognostic value.",[66],"Kidney Failure, Acute",[68,69,70,71,72,73,74,75,76],"transjugular intrahepatic portosystemic shunt (TIPS)","non-invasive assessments","circulating biomarkers","Transthoracic echocardiography (TTE) with Speckle-tracking","Elastography","Contrast-enhanced ultrasound","Computer tomography scan (CT-scan)","Magnetic resonance imaging (MRI)","Urine biomarker","2022-05-17",{"date":79,"type":80},"2022-05-18","ACTUAL",{"date":82,"type":80},"2021-01-01",{"date":84,"type":62},"2030-07-01",{"name":5,"class":6},1]